Isofol Medical AB (publ) announced that Thomas Andersson, at his own request, has chosen to resign as Chief Executive Officer of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 SEK | +0.70% | +3.00% | -1.37% |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Feb. 20 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-1.37% | 10.8M | |
+14.92% | 78.65B | |
+9.32% | 8.94B | |
-10.76% | 5.16B | |
+54.31% | 4.85B | |
+11.19% | 4.19B | |
-22.37% | 2.32B | |
+11.90% | 2.29B | |
-30.09% | 2.19B | |
+20.63% | 2.19B |
- Stock Market
- Equities
- ISOFOL Stock
- News Isofol Medical AB
- Isofol Medical AB Announces Resignation of Thomas Andersson as CEO